News archives


OCTOBER - DECEMBER 17

JULY - SEPTEMBER 17

APRIL - JUNE 17

JANUARY - MARCH 17

OCTOBER - DECEMBER 16

JULY - SEPTEMBER 16

APRIL - JUNE 16

JANUARY - MARCH 16

OCTOBER - DECEMBER 15

JULY - SEPTEMBER 15

APRIL - JUNE 15

JANUARY - MARCH 15

OCTOBER - DECEMBER 14

JULY - SEPTEMBER 14

APRIL - JUNE 14

JANUARY - MARCH 14

OCTOBER - DECEMBER 13

JULY - SEPTEMBER 13

APRIL - JUNE 13

JANUARY - MARCH 13

OCTOBER - DECEMBER 12

JULY - SEPTEMBER 12

APRIL - JUNE 12

JANUARY - MARCH 12

OCTOBER - DECEMBER 11

JULY - SEPTEMBER 11

APRIL - JUNE 11

JANUARY - MARCH 11

OCTOBER - DECEMBER 10

JULY - SEPTEMBER 10

APRIL - JUNE 10

JANUARY - MARCH 10

OCTOBER - DECEMBER 09

JULY - SEPTEMBER 09

APRIL - JUNE 09

JANUARY - MARCH 09

OCTOBER - DECEMBER 08

JULY - SEPTEMBER 08

APRIL - JUNE 08

JANUARY - MARCH 08

OCTOBER - DECEMBER 07

JULY - SEPTEMBER 07

APRIL - JUNE 07

JANUARY - MARCH 07

 
  current news   Press   selected story    
     
  17 October 2014  
  Modelling Cerebrovascular Pathophysiology In Amyloid-ß Metabolism Using Neural Crest-Derived Smooth Muscle Cells
 
 




Authors
Christine Cheung1,2,*, Yeek Teck Goh1, Jingxian Zhang1, Chenghan Wu3, Ernesto Guccione1,4


1 Institute of Molecular and Cell Biology, 61 Biopolis Drive, Proteos, Singapore 138673
2 Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, 1E Kent   Ridge Road, NUHS Tower Block, Singapore 119228
3 Faculty of Medicine, Nursing and Health Sciences, Monash University, 246 Clayton Road, Victoria 3168,   Australia
4 Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore,   Singapore 119074, Singapore

*Correspondence: ccheung@imcb.a-star.edu.sg

Published in Cell Reports on 2nd October 2014.

Abstract
There is a growing recognition of cerebrovascular contribution to neurodegenerative diseases. In the walls of cerebral arteries, amyloid-beta (Aβ) accumulation is evident in a majority of aged people and patients with cerebral amyloid angiopathy. Here, we leverage on human pluripotent stem cells to generate vascular smooth muscle cells (SMCs) from neural crest progenitors, recapitulating brain vasculature-specific attributes in Aβ metabolism. We confirm that the lipoprotein receptor, LRP1, functions in our neural crest-derived SMCs to mediate Aβ uptake and intracellular lysosomal degradation. Hypoxia significantly compromises the ability of SMCs in Aβ clearance by suppressing LRP1 expression. This enables us to develop an assay of Aβ uptake using the neural crest-derived SMCs with hypoxia as a stress paradigm. We then tested several vascular protective compounds in a high throughput format, demonstrating the value of stem cell-based phenotypic screening for novel therapeutics and drug repurposing, which aim at alleviating amyloid burden.

For more information on Christine CHEUNG's laboratory, please click here.